ROSWELL PARK CANCER INSTITUTE

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
First Posted Date
2004-05-20
Last Posted Date
2015-10-06
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
35
Registration Number
NCT00002578
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Not Applicable
Completed
Conditions
First Posted Date
2004-05-19
Last Posted Date
2013-02-05
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00003186
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 3
Completed
Conditions
First Posted Date
2004-05-19
Last Posted Date
2013-02-04
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00002985
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-05-17
Last Posted Date
2011-03-09
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
12
Registration Number
NCT00083148
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-05-13
Last Posted Date
2013-02-04
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00002936
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-04-27
Last Posted Date
2013-02-05
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00002964
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase 2
Completed
Conditions
First Posted Date
2004-03-31
Last Posted Date
2011-03-07
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
24
Registration Number
NCT00004248
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-02-04
Last Posted Date
2013-02-05
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00014066
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors

First Posted Date
2004-01-27
Last Posted Date
2011-03-07
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
10
Registration Number
NCT00003882
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Roswell Park Cancer Institute, Buffalo, New York, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath